Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children

Background: In 2010, Greenland introduced the 13-valent pneumococcal conjugate vaccine (Prevnar 13®– PCV-13) in the childhood immunisation program. The authors aimed to evaluate the impact of PCV-13 on nasopharyngeal carriage of bacteria frequently associated with respiratory infections in children....

Descripción completa

Detalles Bibliográficos
Autores principales: Navne, Johan Emdal, Koch, Anders, Slotved, Hans-Christian, Andersson, Mikael, Melbye, Mads, Ladefoged, Karin, Børresen, Malene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497538/
https://www.ncbi.nlm.nih.gov/pubmed/28467237
http://dx.doi.org/10.1080/22423982.2017.1309504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497538/
https://www.ncbi.nlm.nih.gov/pubmed/28467237
http://dx.doi.org/10.1080/22423982.2017.1309504

Ejemplares similares